Indeed, PASMCs from patients with mutations in bone morphogenetic protein receptor 2 (bmpr2), which cause heritable PAH, were shown to have decreased hepcidin expression, increased FPN levels, reduced intracellular iron levels, and increased levels of ET-1. The gene discussed is HAMP; the disease is pulmonary arterial hypertension.